BEXAGLIFLOZIN | BEXAGLIFLOZIN | ATC A10BK08
METABOLISM SODIUM-GLUCOSE CO-TRANSPORTER 2 (SGLT2) INHIBITOR ANTIDIABETIC REDUCES RENAL REABSORPTION OF FILTERED GLUCOSE TREATMENT OF TYPE 2 DIABETES MELLITUS | ORAL | Cmax 288 NANOMOLAR Tmax 3 HOUR VD 262 LITER PPB 93 PERCENT Cl 19.1 LITER / HOUR HT 12 HOUR SOLUBILITY SLIGHTLY SOLUBLE IN WATER | SODIUM-GLUCOSE CO-TRANSPORTER 2 SGLT2 | sodium-glucose co-transporter 2 UNIPROT P31639 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |